Neelature Sriramareddy, S. (2017). Inactivation of DNA damage repair provides additional efficacy to the treatment of thyroid cancer [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/208422 |
Staumont, B., Costa, C., Vandermeers, F., Neelature Sriramareddy, S., Mascaux, C., Scherpereel, A., DUYSINX, B., LOUIS, R., DELVENNE, P., Hubert, P., & Willems, L. (01 February 2017). EGFR tyrosine kinase inhibitors overcome resistance to chemotherapy in malignant pleural mesothelioma [Poster presentation]. GIGA conference day: New insights into the hallmarks of cancer. |
Staumont, B., Costa, C., Vandermeers, F., Neelature Sriramareddy, S., Mascaux, C., Scherpereel, A., DUYSINX, B., LOUIS, R., DELVENNE, P., Hubert, P., & Willems, L. (2016). EGFR tyrosine kinase inhibitors overcome resistance to chemotherapy in malignant pleural mesothelioma. In Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016. Peer reviewed |
Hamaïdia, M., Barez, P.-Y., Carpentier, A., Lebecque, S., Miazek, K., Paul, A., Neelature Sriramareddy, S., Staumont, B., Danthine, S., Deleu, M., Frederich, M., De Pauw, E., Delaplace, P., Delvigne, F., Goffin, D., Ongena, M., Duysinx, B., Louis, R., cosse, J.-P., & Willems, L. (2016). From Valeriana officinalis to cancer therapy: the success of a bio-sourced compound. Biotechnologie, Agronomie, Société et Environnement, 20 (S1), 314-320. Peer Reviewed verified by ORBi |
Neelature Sriramareddy, S., Staumont, B., & Willems, L. (03 December 2015). Targeting cell cycle checkpoints and DNA damage response in Thyroid cancer [Poster presentation]. 28th Televie Seminar. |
Barez, P.-Y., De Brogniez, A., Carpentier, A., Gazon, H., Gillet, N., Gutiérrez, G., Hamaïdia, M., Jacques, J.-R., Perike, S., Neelature Sriramareddy, S., Renotte, N., Staumont, B., Reichert, M., Trono, K., & Willems, L. (24 November 2015). Recent advances in BLV research. Viruses, 7 (11), 6080-6088. doi:10.3390/v7112929 Peer Reviewed verified by ORBi |
Neelature Sriramareddy, S., Staumont, B., & Willems, L. (13 May 2015). Targeting cell cycle checkpoints and DNA damage response in Thyroid cancer [Paper presentation]. GIGA Cancer Day. |
Staumont, B., Neelature Sriramareddy, S., & Willems, L. (27 January 2015). Targeting cell cycle checkpoints and DNA damage response in malignant pleural mesothelioma [Poster presentation]. GIGA conference day: Current advances in medical genetics and genomics. |
Neelature Sriramareddy, S., Staumont, B., & Willems, L. (27 January 2015). Targeting cell cycle checkpoints and DNA damage response in Thyroid cancer [Poster presentation]. GIGA Day-Current Advances in Medical Genetics and Genomics. |
Neelature Sriramareddy, S., Staumont, B., & Willems, L. (2014). DNA Damage and Thyroid Cancer. GIGADay-2014. |
Neelature Sriramareddy, S., Vandermeers, F., Costa, C., Mascaux, C., Scherpereel, A., Delvenne, P., & Willems, L. (15 April 2013). The role of TGFalpha in the resistance to mesothelioma chemotherapy [Paper presentation]. AACR 104th Annual Meeting 2013; Apr 610, 2013; Washington, DC. doi:10.1158/1538-7445.AM2013-984 |
Neelature Sriramareddy, S.* , Vandermeer, F.* , costa, C.* , & Willems, L.*. (2013). The role of TGFalpha in the resistance to mesothelioma chemotherapy. GIGA-Day 2013. * These authors have contributed equally to this work. |
Vandermeers, F., Neelature Sriramareddy, S., Chrisostome, C., Hubaux, R., Cosse, J.-P., & Willems, L. (2013). The role of epigenetics in malignant pleural mesothelioma. Lung Cancer, 81, 311-318. doi:10.1016/j.lungcan.2013.05.014 Peer Reviewed verified by ORBi |